Market News

Cronos Group Inc. to Speak at Stifel Canada's 3rd Annual Future of Healthcare Conference

Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) ("Cronos" or the "Company"), an innovative global cannabinoid company, today announced that Mike Gorenstein, Chairman, President and Chief Executive Officer, will speak at Stifel Canada's 3 rd Annual Future of Healthcare Conference on Wednesday, December 7, 2022 at 1:00 p.m. ET.

A webcast will be available on the Investors section of the Company's website at: https://ir.thecronosgroup.com/events-presentations .

About Cronos
Cronos is an innovative global cannabinoid company committed to building disruptive intellectual property by advancing cannabis research, technology and product development. With a passion to responsibly elevate the consumer experience, Cronos is building an iconic brand portfolio. Cronos' diverse international brand portfolio includes Spinach ® , PEACE NATURALS ® , Lord Jones ® , Happy Dance ® and PEACE+ ® . For more information about Cronos and its brands, please visit: thecronosgroup.com .

Forward-looking Statements
This press release may contain information that may constitute "forward-looking information" or "forward-looking statements" within the meaning of applicable Canadian and U.S. securities laws and court decisions (collectively, "Forward-looking Statements"). All information contained herein that is not clearly historical in nature may constitute Forward-looking Statements. In some cases, Forward-looking Statements can be identified by the use of forward-looking terminology such as "may", "will", "expect", "plan", "anticipate", "intend", "potential", "estimate", "believe" or the negative of these terms, or other similar expressions intended to identify Forward-looking Statements. Some of the Forward-looking Statements contained in this press release include the Company's intention to build an international iconic brand portfolio and develop disruptive intellectual property. Forward-looking Statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable by management, are inherently subject to significant business, economic and competitive risks, financial results, results, performance or achievements expressed or implied by those Forward-looking Statements and the Forward-looking Statements are not guarantees of future performance. A discussion of some of the material risks applicable to the Company can be found in the Company's Annual Report on Form 10-K for the year ended December 31, 2021, Quarterly Report on Form 10-Q for the period ended March 31, 2022, Quarterly Report on Form 10-Q for the period ended June 30, 2022, and Quarterly Report on Form 10-Q for the period ended September 30, 2022, all of which have been filed on SEDAR and EDGAR and can be accessed at www.sedar.com and www.sec.gov/edgar, respectively. Any Forward-looking Statement included in this press release is made as of the date of this press release and, except as required by law, Cronos disclaims any obligation to update or revise any Forward-looking Statement. Readers are cautioned not to put undue reliance on any Forward-looking Statement.

Cronos Group Contact
Shayne Laidlaw
Investor Relations
Tel: (416) 504-0004
investor.relations@thecronosgroup.com


Primary Logo

News Provided by GlobeNewswire via QuoteMedia

CRON:CA,CRON
Cannabis Investing

Ongoing Growth in North America’s Cannabis Space

An article curated by Bazinga highlighted the cannabis market trends from last week. Even though last week was short, the cannabis sector was a busy. The article went on to highlight a number of the cannabis companies looking preparing for their IPOs, among other cannabis related news.

The article went on to highlight the Flowr Corporation as one of numerous companies looking to go public by the end of the year. Flowr’s management team is responsible for the creation and success of MedReleaf, an R&D focused company in the medical cannabis space. In preparation for its RTO in Canada, the company has raised $36 million in financing.

Keep reading...Show less
cannabis weekly graphic stock down

Cannabis Weekly Round-Up: Tilray Drops US$4B 2024 Sales Forecast

A new report shows a leading Canadian cannabis producer will no longer meet its bold sales target by the end of 2024.

Health Canada has issued a warning to a cannabis producer after a new product caught the attention of the market and regulators for its THC limit avoidance.

Keep reading to find out more cannabis highlights from the past five days.

Keep reading...Show less

Trulieve Introduces New Products to Massachusetts for February

Two popular proprietary cannabis brands Modern Flower and Roll One will launch statewide

TALLAHASSEE, Fla. , Feb. 3, 2023 /CNW/ -- Trulieve Cannabis Corp. (CSE: TRUL ) (OTCQX: TCNNF ) ("Trulieve '' or "the Company''), a leading and top-performing cannabis company in the United States , today announced the February launch of two of its proprietary brands in Massachusetts , Roll One on February 3 and Modern Flower on February 10 .

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less

Trulieve Introduces New Products to West Virginia in February

Two popular proprietary cannabis brands Modern Flower and R.O. will launch with festivities

TALLAHASSEE, Fla. , Feb. 3, 2023 /CNW/ -- Trulieve Cannabis Corp. (CSE: TRUL ) (OTCQX: TCNNF ) ("Trulieve '' or "the Company''), a leading and top-performing cannabis company in the United States , today announced the February launch of two of its proprietary brands in West Virginia , R.O. on February 3 and Modern Flower on February 10 .

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less
Tinley's Announces Plans for Own-Brand Expansion to Accelerate Revenue Growth

Tinley's Announces Plans for Own-Brand Expansion to Accelerate Revenue Growth

Provides Corporate Updates

The Tinley Beverage Company Inc. (CSE: TNY) (OTCQB: TNYBF) ("Tinley's" or the "Company") is pleased to provide updates on Company initiatives aimed to achieve revenue growth through the expansion of the Tinley's and Beckett's brands.

News Provided by Newsfile via QuoteMedia

Keep reading...Show less

Centurion Provides Project Review and 2023 Plans; Announces Private Placement

Centurion Minerals Ltd. (TSXV: CTN) ("Centurion", or the "Company") wishes to summarize its 2022 achievements and provide an overview of its Canadian gold exploration project, 2023 plans, and objectives, as follows:

  1. Casa Berardi West Gold Project Acquisition: Proceeding with its original focus of acquiring and advancing gold exploration projects, the Company executed an Option Agreement in August 2022 to acquire a 100% interest in the Casa Berardi West Gold Project (the "Project"). The Project consists of 3 claim groups (Noseworthy, Newman and Hepburn) comprising a total of 4,700 hectares, strategically located northeast of Cochrane, Ontario, Canada in the mineral endowed central north Abitibi greenstone belt.

A NI 43-101 Technical Report outlining the Project's historical activities has been completed and can be found on the Company's website. (Casa Berardi West - Centurion Minerals Ltd).

News Provided by Newsfile via QuoteMedia

Keep reading...Show less

TerrAscend Closes on Acquisition of High-Performing Dispensary in Maryland

The 10,000 square foot Allegany Medical Marijuana Dispensary is located in Northwest Maryland within six miles of both the West Virgina and Pennsylvania borders

The acquisition complements TerrAscend's fully operational, state-of-the-art 150,000 square foot cultivation and processing facility in Hagerstown, MD and expands the Company's retail footprint to 32 dispensaries nationwide

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less

Latest Press Releases

Related News

×